ArticleEClinicalMedicine2025

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysis.

Na Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.